Susannah Gray's most recent trade in 4D Molecular Therapeutics Inc was a trade of 22,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Maravai LifeSciences Holdi... | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 2.16 per share. | 16 Jun 2025 | 89,139 | 169,907 | - | 2.2 | 192,540 | Class A Common Stock |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 24,258 | 24,258 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 10,649 | 42,137 (0%) | 0% | 0 | Ordinary Shares | |
| Morphic Holding Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,168 | 23,168 | - | - | Common Stock | |
| Maravai LifeSciences Holdi... | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 23 May 2024 | 20,645 | 80,768 | - | 10.8 | 222,553 | Class A Common Stock |
| 4D Molecular Therapeutics Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 23,576 | 23,576 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 10,537 | 31,488 (0%) | 0% | 0 | Ordinary Shares | |
| Maravai LifeSciences Holdi... | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 24,000 | 60,123 | - | 0 | Class A Common Stock | |
| Morphic Holding Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,535 | 12,535 | - | - | Director Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,044 | 22,044 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,132 | 20,951 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 28,000 | 28,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 10,131 | 10,131 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 4,666 | 4,666 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 1,688 | 11,819 (0%) | 0% | 0 | Ordinary Shares | |
| 4D Molecular Therapeutics Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Maravai LifeSciences Holdi... | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 4,271 | 36,123 | - | 0 | Class A Common Stock | |
| Morphic Holding Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Morphic Holding Inc | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 24,000 | 24,000 | - | - | Stock Option (right to buy Common Stock) | |
| Maravai LifeSciences Holdi... | Susannah Gray | Director | Purchase of securities on an exchange or from another person at price $ 27.00 per share. | 24 Nov 2020 | 20,000 | 31,852 | - | 27 | 540,000 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 11,852 | 11,852 | - | 0 | Class A Common Stock |